P-Glycoprotein Function: Association with Race, Gender and Tacrolimus Pharmacokinetics

被引：0
作者：
Tornatore, K. [1 ,4 ]
Minderman, H. [2 ]
Attwood, K. [3 ]
O'Loughlin, K. [2 ]
Venuto, R. [4 ]
机构：
[1] Sch Pharm, Translat Pharmacol Res, Buffalo, NY USA
[2] Roswell Pk Canc Inst, Flow Cytometry Lab, Buffalo, NY 14263 USA
[3] Sch Publ Hlth, Biostat, Buffalo, NY USA
[4] UB, Sch Med, Med, Buffalo, NY USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
335
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
[31]   Pharmacokinetics of talinolol is modified by barnidipine: implication of P-glycoprotein modulation [J].
Ozturk, N. ;
Ozturk, D. ;
Pala-Kara, Z. ;
Okyar, A. .
PHARMAZIE, 2017, 72 (01) :29-34
[32]   Coadministration of P-Glycoprotein Modulators on Loperamide Pharmacokinetics and Brain Distribution [J].
Montesinos, Rita Nieto ;
Moulari, Brice ;
Gromand, Jessica ;
Beduneau, Arnaud ;
Lamprecht, Alf ;
Pellequer, Yann .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) :700-706
[33]   Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein [J].
Shimizu, M ;
Uno, T ;
Sugawara, K ;
Tateishi, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (05) :538-544
[34]   Absence of P-Glycoprotein Transport in the Pharmacokinetics and Toxicity of the Herbicide Paraquat [J].
Lacher, Sarah E. ;
Gremaud, Julia N. ;
Skagen, Kasse ;
Steed, Emily ;
Dalton, Rachel ;
Sugden, Kent D. ;
Cardozo-Pelaez, Fernando ;
Sherwin, Catherine M. T. ;
Woodahl, Erica L. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (02) :336-345
[35]   Does P-glycoprotein play a role in anticancer drug pharmacokinetics? [J].
Sparreboom, A ;
Nooter, K .
DRUG RESISTANCE UPDATES, 2000, 3 (06) :357-363
[36]   Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib [J].
C. Jovelet ;
A. Deroussent ;
S. Broutin ;
A. Paci ;
R. Farinotti ;
J. M. Bidart ;
S. Gil .
European Journal of Drug Metabolism and Pharmacokinetics, 2013, 38 :149-157
[37]   Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis [J].
Tsai, TH ;
Lee, CH ;
Yeh, PH .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (06) :1245-1252
[38]   Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist [J].
Lush, RM ;
Meadows, B ;
Fojo, AT ;
Kalafsky, G ;
Smith, HT ;
Bates, S ;
Figg, WD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (02) :123-128
[39]   Pharmacodynamics and pharmacokinetics of risperidone and paliperidone with respect to P-glycoprotein expression [J].
Kirschbaum, K. M. ;
Henken, S. ;
Hiemke, C. ;
Schmitt, U. .
PHARMACOPSYCHIATRY, 2007, 40 (05) :224-224
[40]   Role of P-glycoprotein in Regulating the Efficacy, Toxicity and Pharmacokinetics of Yunaconitine [J].
Li, Xiaocui ;
Liang, Qi ;
Wang, Caiyan ;
Qiu, Huawei ;
Lin, Tingting ;
Li, Wentao ;
Zhang, Rong ;
Liu, Zhongqiu ;
Zhu, Lijun .
CURRENT DRUG METABOLISM, 2024, 25 (05) :317-329
12345